Intrauterine growth restriction and the innate immune system in preterm infants of ≤32 weeks gestation

Birte Tröger1, Thilo Müller, Kirstin Faust

  • 1Department of Paediatrics, University of Lübeck, Lübeck, Germany.

Neonatology
|January 9, 2013
PubMed

Insights

Small for gestational age (SGA) preterm infants show altered immune cell counts and reduced cytokine responses. These differences in innate immunity may contribute to adverse neonatal outcomes, warranting further investigation.

Area of Science:

  • Neonatal immunology
  • Perinatal medicine
  • Innate immune responses

Background:

  • Intrauterine growth restriction (IUGR) is linked to poor neonatal outcomes.
  • IUGR may affect the development of innate immune responses.
  • Investigating immune parameters in preterm small for gestational age (SGA) infants is crucial.

Purpose of the Study:

  • To investigate innate immune response parameters in preterm infants (≤32 weeks gestation) who are small for gestational age (SGA).
  • To compare clinical data and immune responses between SGA and appropriate for gestational age (AGA) preterm infants.

Main Methods:

  • Comparison of clinical data between SGA (n=20) and AGA (n=124) preterm infants (≤32 weeks gestation).
  • Analysis of full blood counts at birth, day 3, and day 7.
  • Assessment of cytokine immune responses using a whole cord blood assay stimulated with lipopolysaccharides.

Main Results:

  • SGA preterm infants faced higher risks of mortality or bronchopulmonary dysplasia.
  • Diminished white blood cells and neutrophils were observed in SGA infants at birth and day 3.
  • Lower concentrations of interleukin-6 and interleukin-10 were found in SGA infants post-stimulation.

Conclusions:

  • SGA preterm infants exhibit distinct differences in blood counts and innate immune response capabilities compared to AGA infants.
  • The role of quantitative deficiencies in innate immunity in adverse outcomes requires further study in larger trials.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...